GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 743 filers reported holding GLAXOSMITHKLINE PLC in Q1 2015. The put-call ratio across all filers is 1.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $211,000 | 0.0% | 4,847 | +0.1% | 0.04% | +13.9% |
| Q1 2022 | $211,000 | 0.0% | 4,843 | +1.0% | 0.04% | -2.7% |
| Q4 2021 | $211,000 | +1.4% | 4,794 | -8.2% | 0.04% | -9.8% |
| Q2 2021 | $208,000 | 0.0% | 5,221 | +2.4% | 0.04% | -29.3% |
| Q2 2020 | $208,000 | -5.5% | 5,100 | +9.1% | 0.06% | -4.9% |
| Q4 2019 | $220,000 | +6.3% | 4,676 | -2.9% | 0.06% | -20.8% |
| Q2 2017 | $207,000 | +2.0% | 4,816 | 0.0% | 0.08% | -4.9% |
| Q1 2017 | $203,000 | -1.0% | 4,816 | +1.2% | 0.08% | -14.7% |
| Q3 2016 | $205,000 | -0.5% | 4,758 | 0.0% | 0.10% | -5.0% |
| Q2 2016 | $206,000 | -3.3% | 4,758 | -9.9% | 0.10% | -4.8% |
| Q4 2015 | $213,000 | -8.2% | 5,278 | -12.4% | 0.10% | -16.0% |
| Q3 2015 | $232,000 | +11.5% | 6,023 | +20.8% | 0.12% | +11.6% |
| Q2 2015 | $208,000 | -9.6% | 4,985 | 0.0% | 0.11% | -15.2% |
| Q1 2015 | $230,000 | +3.1% | 4,985 | -4.6% | 0.13% | +0.8% |
| Q4 2014 | $223,000 | – | 5,228 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Black Creek Investment Management Inc. | 7,951,626 | $318,224,000 | 10.49% |
| Healthcare Value Capital, LLC | 120,000 | $4,802,000 | 9.01% |
| KAHN BROTHERS GROUP INC | 1,605,014 | $64,232,661,000 | 8.03% |
| Eversept Partners, LP | 693,685 | $28,091,890 | 7.87% |
| EQUITY INVESTMENT CORP | 2,673,764 | $107,004,000 | 3.74% |
| Sio Capital Management, LLC | 379,500 | $15,188,000 | 3.66% |
| Martin Capital Partners, LLC | 115,448 | $4,620,000 | 3.27% |
| Circle Road Advisors LP | 53,028 | $2,122,000 | 3.10% |
| Keystone Financial Planning, Inc. | 156,968 | $6,282,000 | 3.07% |
| CAMG Solamere Management, LLC | 160,294 | $6,415,000 | 2.94% |